This October, members of the Duke Neurology Department contributed to 11 new peer-reviewed journal articles, advancing the fields of clinical and translational neuroscience. Highlights from the past 31 days include descriptions of a new technology that uses retinal scans to detect mild cognitive impairment, a white paper outlining challenges and opportunities for clinical trials in Alzheimer's disease, and genetic analyses that advance our understanding of the origins of Alzheimer’s disease.
Junjie Yao, PhD, grew up dreaming about the potential health applications of combining engineering and biology. Yao pursued this passion through his graduate studies and then joined the biomedical engineering program at Duke, where he studied an emerging imaging technology known as photoacoustic tomography (PAT).
The month of September saw 20 new peer-reviewed journal articles articles and one book chapter from members of the Duke Neurology Department.
A new blood-based test for Parkinson’s disease, improved monitoring techniques for epilepsy, and a chapter discussing the use of transcranial magnetic stimulation (TMS) as a noninvasive treatment for dystonia are just a few examples of the latest research from members of the Duke Neurology Department.
Local middle school students visited Duke this August to touch human brains, learn about the U.S. health system, and watch research being conducted in real time, thanks to the BOOST (Building Opportunities and Overtures in Science and Technology) program and the Duke Neurology Department.
This July, members of the Duke Neurology Department contributed to 10 new peer-reviewed journal articles. Highlights of this research include a new study that found persistent associations between neighborhood income levels and poor outcomes for neurocritical care, a trio of studies that provide insights into the origins and development of Alzheimer’s disease, and a preliminary analysis of the merits of a potential off-label therapy for ALS.
A promising new therapy for brain tumors detailed in the New England Journal of Medicine and a validation of a popular stroke treatment for patients taking vitamin K antagonists published in JAMA are just two highlights of the 15 peer-reviewed journal articles authored by members of the Duke Neurology Department this June.
JAMA Study Validates Low Risk of Endovascular Therapy for Stroke Patients Taking Vitamin K Antagonists
A new study in JAMA offers good news for the roughly two million Americans taking vitamin K antagonists (VKAs): VKAs do not appear to increase risk for complications from endovascular thrombectomy (EVT), a lifesaving form of “keyhole surgery” used to treat the most common form of stroke.
This May, members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles. Highlights of this research include the first study to examine trauma-associated sleep disorder among U.S. veterans, the development of a highly sensitive microscopic technique to identify the regions in the brain where seizures begin, and a small but innovative trial showing early promise for a potential alternative therapy for amyotrophic lateral sclerosis (ALS).